Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article discussing the impact of the Supreme Court’s recent holding in Amgen v. Sanofi concerning patent law’s enablement requirement;
- a blog post highlighting the “Supreme Court’s [n]on-[e]ngagement with the Federal Circuit” in Amgen v. Sanofi; and
- an article analyzing two recent appeals concerning the constitutionality of state laws “that target companies that generate revenue through patent licensing and infringement litigation rather than producing protected inventions.”